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Summary
Obesity before and during pregnancy leads to reduced offspring cardiometabolic
health. Here, we systematically reviewed animal experimental evidence of maternal
obesity before and during pregnancy and offspring anthropometry and cardiometa-
bolic health. We systematically searched Embase and Medline from inception until
January 2018. Eligible publications compared offspring of mothers with obesity to
mothers with a normal weight. We performed meta‐analyses and subgroup analyses.
We also examined methodological quality and publication bias. We screened
2543 publications and included 145 publications (N = 21 048 animals, five species).
Essential methodological details were not reported in the majority of studies. We found
evidence of publication bias for birth weight. Offspring of mothers with obesity had
higher body weight (standardized mean difference (SMD) 0.76 [95% CI 0.60;0.93]), fat
percentage (0.99 [0.64;1.35]), systolic blood pressure (1.33 [0.75;1.91]), triglycerides
(0.64 [0.42;0.86], total cholesterol (0.46 [0.18;0.73]), glucose level (0.43 [0.24;0.63]),
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and insulin level (0.81 [0.61;1.02]) than offspring of control mothers, but similar birth
weight. Sex, age, or species did not influence the effect of maternal obesity on offspring's
cardiometabolic health. Obesity before and during pregnancy reduces offspring
cardiometabolic health in animals. Future intervention studies should investigate
whether reducing obesity prior to conception could prevent these detrimental
programming effects and improve cardiometabolic health of future generations.
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1 | INTRODUCTION
Obesity has reached epidemic proportions, and its worldwide prev-
alence has nearly tripled since 1975.1 Estimates from the World
Health Organization indicated that, in 2016, more than 1.9 billion
adults were overweight, of whom over 650 million were obese.1
The rise in obesity prevalence has been most prominent in women
of reproductive age.2,3 Obesity in pregnancy increases maternal
and neonatal morbidity including preterm birth, congenital anoma-
lies, gestational diabetes, preeclampsia, and increased caesarean
section rate.4-6 More recently, epidemiological studies have shown
that offspring of mothers with obesity are themselves at increased
risk of obesity, cardiometabolic morbidity, and all‐cause mortality,
which is thought to occur independently of genetic transmission
of poor health.7,8 In maternal obesity, the intrauterine environment
is hypothesized to play a key role in the mediation of these effects
on offspring's health—a concept that has been termed developmen-
tal programming.
However, it is still unclear whether maternal obesity is causal to
diminished offspring health, primarily because associations from
observational studies are subject to confounding. For example, various
socio‐demographic, nutritional, lifestyle, and genetic factors may
determine both maternal pre‐pregnancy body mass index (BMI) and
offspring's disease risk.9 Therefore, animal models, which employ a
common genetic background, carefully controlled dietary and activity
conditions, and controlled postnatal environments are imperative for
examining how obesity before and during pregnancy increases the
development of obesity, insulin resistance, and cardiometabolic
disease in the offspring.
Narrative reviews of animal experiments have described the
detrimental effects of maternal obesity on offspring's health.10-12
While valuable, they can be hindered by subjective selection and lack
of appropriate publication bias assessment.13 Existing systematic
reviews of animal experiments focused on the effect of an obesogenic
diet at any time during gestation instead of focusing on the effects of
maternal obesity already present prior to conception.14,15 Animals
models where obesity is present before and during pregnancy are
more reflective of the offspring effects in conceiving women with
obesity. Our objective was to systematically review the available
evidence provided by animal experiments on the effect of maternal
obesity before and during pregnancy on offspring's anthropometry,
cardiovascular, and metabolic outcomes.
2 | METHODS
The conduct and reporting of this review adhered to the guidelines
outlined in the Preferred Reporting Items for Systematic Reviews
and Meta‐analysis (PRISMA) statement.16 Furthermore, this review
was conducted in collaboration with SYstematic Review Center for
Laboratory animal Experimentation (SYRCLE).
2.1 | Study protocol
The review protocol (first version at 28 August 2015 and updated ver-
sion at 3 January 2017) was registered at the website of SYRCLE on
11 January 2017 and can be accessed via the website: www.syrcle.
nl. A few amendments were applied to the study protocol, as outlined
in table S1.
2.2 | Literature search
A medical information specialist (J.L.) performed a systematic search
in OVID MEDLINE (including Epub Ahead of Print, In‐Process, and
Other Non‐Indexed Citations) and OVID EMBASE from inception to
30 January 2018 (final update) using both controlled terms (i.e.,
MESH) and text words. To keep the search broad, so relevant articles
would not be missed, we did not include outcomes in our search, but
searched for the following concepts: (1) animals; (2) prenatal/maternal
exposure (including maternal/intrauterine AND offspring); and (3)
obese (including high fat diet and maternal/body weight/mass).
Reviews, editorials, and conference abstracts (the latter only in
EMBASE) were excluded. No further restrictions were applied. We
cross‐checked the reference lists and the citing studies via Web of
Science for relevant publications and review studies. The biblio-
graphic records retrieved were imported and de‐duplicated in End-
note. The complete search strategies are presented in file S1.
2.3 | Selection process
Two reviewers independently screened all identified studies for eligibility
using Covidence.17 We first screened titles and abstracts of all unique
studies for eligibility in duplo (M.M. screened all; C.vd.B. screened 70%
and S.M. andC.F. screened 15% each). Secondly, we performed eligibility
screening of full text of studies deemed possibly eligible after title and
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abstract screening (M.M. and S.M.). Disagreements were resolved by
discussion or by consulting a third reviewer (R.P.).
2.4 | Eligibility criteria
We only included original animal studies. There was no limitation in
animal species. Studies were eligible if they compared anthropometry
and/or cardiometabolic outcomes of offspring born to females that
were obese before and during pregnancy to offspring born to
females that had a normal weight before and during pregnancy.
Maternal obesity was defined as a statistically significant higher body
weight or a higher fat mass of experimental females compared with
control females. For a study to be eligible, higher body weight
and/or fat mass needed to be present before pregnancy (defined as
prior to mating or at mating), to ensure that offspring were exposed
to maternal obesity during the entire gestational period. Authors
were contacted if they stated that maternal weight or fat mass was
measured prior to conception but weight/fat mass was not reported
in the study. The outcome variables in the offspring were birth
weight, body weight, body fat percentage (BF%), fat mass (FM), sys-
tolic blood pressure (SBP), diastolic blood pressure (DBP), mean arte-
rial pressure (MAP), triglycerides, total cholesterol, high‐density
lipoprotein (HDL) cholesterol, low‐density lipoprotein (LDL) choles-
terol, glucose, insulin, and homeostatic model assessment for insulin
resistance (HOMA‐IR).
We excluded studies for the following reasons: (1) different post-
natal environments between the intervention and control group; (2) no
normal or chow diet of the offspring from weaning onwards; (3) an
additional disease factor in the mother such as severe diabetes; (4)
interventions potentially interfering with the primary effect of
maternal obesity (eg, postnatal leptin injections); (5) lack of a control
group with a normal weight and normal diet (as defined by the
authors of the study); (6) only data on molecular, epigenetic, or fetal
effects; (7) mothers who were made obese by genetic factors or
selective breeding; and (8) reviews, editorials, conference abstracts,
and interviews. When data were published in duplicate (eg, identical
values in multiple journals), we included the data from the first
published study only.
2.5 | Data extraction
Two reviewers (initial search: S.M. and C.F.; update search: S.M., M.M.,
and E.F.) extracted data using a piloted data‐extraction form. Due to
limited resources, we extracted 10% of the studies in duplo, in
which there was minimal discrepancy (2%). We extracted the
following data: (1) general characteristics of the study; (2) animal
species and strain; (3) obesity generating model; (4) mating age; (5)
dietary information of the parental animals and their offspring; (6)
sex of the offspring; (7) litter size adjustment; and (8) cross‐fostering
of the offspring. We present a summary of these characteristics in
table S2.
Outcome values were extracted for data analyses in terms of
means, standard deviations (SDs) or standard errors (SEs), number of
animals (N), and age at time of outcome assessment. If an outcome
was measured at multiple time points in the same animal, we extracted
the last measurement because our focus was on the long‐term effects
of maternal obesity on the offspring. If results were only displayed
graphically, we read the outcomes as precisely as possible using a dig-
ital screen ruler (Adobe Acrobat XI pro), extracting the most conserva-
tive estimate. If the relevant values were not extractable, we
contacted the authors for more information.
2.6 | Quality assessment and risk of publication bias
The methodologic quality of all selected studies was evaluated by
evaluating six of the 10 questions of the SYRCLE risk of bias tool
for animal studies. The SYRCLE risk of bias tool is based on the
Cochrane Risk of Bias tool and has been adjusted for aspects of bias
that play a specific role in animal intervention studies.18 First, we
determined whether three key characteristics of scientific reporting
were mentioned in the study (reporting questions): “randomization,”
“blinding,” and “power calculation.” If studies only reported “blinding”
or “power calculation” concerning outcomes not of interest to our
study, we scored it as “no.” When the key characteristics were men-
tioned in the study, we hand searched the full text for the answers
to the corresponding risk of bias questions of the SYRCLE Risk of
Bias tool. We did not exclude studies based on poor quality. The
answers to all questions were displayed separately, and no aggre-
gated quality was determined (table S3). We performed Duval and
Tweedie's Trim and Fill analysis to investigate possible publication
bias, when a minimum of 15 studies were available on any particular
outcome.19 We used the inverse of the standard error as precision
estimate.20
2.7 | Data analysis
The statistical analyses and forest plots were conducted using Review
Manager (RevMan, Version 5.3. Copenhagen: The Nordic Cochrane
Centre, The Cochrane Collaboration, 2014). We performed meta‐
analyses for each outcome with more than two studies available. Stud-
ies were excluded from meta‐analyses when not all outcome data
(mean, SD, and N) could be obtained. We calculated the standardized
mean difference (SMD) and 95% confidence interval (95% CI) for each
separate intervention‐control comparison group with Hedges' g cor-
rection.21 If a study contained more than one experimental group of
animals with obesity with similar methods of obesity induction that
were compared with the control group, then the experimental groups
were pooled. In the meta‐analysis, the individual SMDs were pooled
to obtain an overall SMD and 95% CI for the respective outcome.
Due to anticipated heterogeneity, we used a random effects model
for the meta‐analyses. Heterogeneity between studies was assessed
by the I2 statistics.22 We accepted any degree of heterogeneity for
meta‐analyses. We defined low, moderate, and high heterogeneity
according to I2 cut‐offs of 25%, 50%, and 75%, respectively.23 We
performed pre‐defined subgroup analyses for sex (male, female, over-
all), age (infancy, juvenile, adult), and species (rodents, non‐rodents)
provided the subgroups contained a minimum of three independent
studies. We considered P‐values of less than 0.05 as statistically
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significant. For the subgroup analyses, we adjusted our significance
level according to the conservative Bonferroni method to account
for multiple analyses (p* number of comparisons).24 If the direction
of the effect between subgroups were statistically significantly differ-
ent from each other, we considered the subgroups to (partly) explain
the observed heterogeneity.
3 | RESULTS
3.1 | Search results
The systematic literature search yielded 2543 unique references
(Figure 1, PRISMA flowchart). Three studies that appeared eligible
after title and abstract screening were not retrievable, also after
contacting the authors. Of the remaining 540, 396 studies failed to
meet the inclusion criteria and were excluded (reasons indicated in
Figure 1). We included one additional study after searching the refer-
ences of relevant publications. Eventually, we included 145 studies for
data extraction (see supplementary file 2). There were a total of
21 048 animals in 474 comparisons across 13 outcomes included in
meta‐analyses.
3.2 | Study characteristics
A general description of the included studies is provided in table S2.
Most studies reported on rodents (rats N = 76, mice N = 59). Other
studies reported on sheep (N = 5), pigs (N = 3), and non‐human primates
(N = 2). The median time of obesity induction was 6 weeks before mat-
ing (inter quartile range [IQR] 5.0; 8.7,N = 136 reported). Median age at
mating was 13 weeks (IQR 11.2; 16.0,N = 107 reported). Maternal obe-
sity was defined as an increased maternal body weight in the interven-
tion group relative to the control group in most studies (N = 138, 95%),
and as higher fat mass in a minority of studies (N = 7, 5%).
Outcomes reported on in studies were offspring's anthropometry
(N = 139, 96%), blood pressure (N = 11, 8%), glucose homeostasis
(including glucose and insulin levels) (N = 87, 60%), and lipid profile
(N = 51, 35%). Five studies (3%) reported on all four outcome catego-
ries. The largest number of studies reported on offspring's body
weight (N = 123, 85%) and insulin (N = 70, 48%), while a limited num-
ber of studies reported on HDL cholesterol (N = 5), DBP (N = 4), and
LDL cholesterol (N = 4). The largest number of offspring was included
in the meta‐analysis on birth weight (N = 6530 animals, N = 63 stud-
ies), and the smallest number on LDL cholesterol (N = 78 animals,
N = 4 studies). Figure 2 provides overall effect estimates of maternal
obesity for each offspring outcome.
FIGURE 1 PRISMA flowchart
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3.3 | Anthropometry
Birth weight was obtained from N = 63 studies (N = 6530 offspring),
one study was included twice in meta‐analysis since they reported
on two separate cohorts.25 In six studies, data on birth weight was
not extractable.26-31 There was no difference in birth weight between
offspring of mothers with obesity and offspring of mothers with a nor-
mal weight, SMD −0.05 [95% CI −0.17; 0.07], I2 = 74% (figure S1).
Body weight of offspring was obtained from N = 123 studies
(N = 5772 offspring), two studies were included twice in the meta‐
analysis since they reported on two separate cohorts.25,32 Body
weight was measured at age 4 days up to 13 months. We were unable
to extract outcome data from four studies.26,31,33,34 Offspring's body
weight was increased following maternal obesity, SMD 0.76 [95% CI
0.60; 0.93], I2 = 86% (figure S2).
BF% was obtained from N = 32 studies (N = 1284 animals) and
measured from birth up to 22 months of age. We were unable to
extract data from one study.35 The meta‐analysis showed higher
BF% in offspring of mothers with obesity, SMD 0.99 [95% CI 0.64;
1.35], I2 = 83% (figure S3). Data obtained from 10 studies showed
higher FM in offspring of mothers with obesity, SMD 1.26 [95% CI
0.52; 2.00], I2 = 80% (figure S4).
3.4 | Blood pressure
Blood pressure was measured via a tail cuff (N = 6 studies) or
invasively by remote radio‐telemetry after surgical implantation of
carotid artery probes (N = 5 studies).36-40 Effect estimates did not dif-
fer substantially between both methods.
SBP was obtained from nine studies, including N = 251 animals
between 8 and 24 weeks of age. Offspring of mothers with obesity
had higher SBP compared with offspring of control mothers, SMD
1.33 [95% CI 0.75; 1.91], I2 = 73% (figure S5). Offspring's DBP was
only reported in four studies, including N = 129 animals between 12
and 23 weeks of age, and the difference between offspring of mothers
with obesity and offspring of mothers with a normal weight did not
achieve statistical significance, SMD 0.84 [95% CI −0.08; 1.74],
I2 = 81% (figure S6). MAP was measured invasively, and one of two
studies reported a statistically significantly higher MAP in offspring
of mothers with obesity.39,40
3.5 | Lipid profile
Data on offspring triglyceride levels were available from N = 46 stud-
ies, including N = 1337 animals between 1 day and 12 months of age.
We could not obtain data from one study.41 Offspring of mothers with
obesity had higher triglycerides levels compared with offspring of con-
trol mothers, SMD 0.64 [95% CI 0.42; 0.86], I2 = 69% (figure S7).
Data from N = 27 articles, including N = 795 animals between
21 days and 12 months of age, showed that offspring of mothers with
obesity had higher total cholesterol levels compared with offspring of
control mothers, SMD 0.46 [95% CI 0.18; 0.73], I2 = 69% (figure S8).
No difference in HDL cholesterol between offspring of mothers
with obesity and offspring of mothers with a normal weight was
observed in five studies, including N = 158 animals between 28 days
and 12 months of age, with a SMD of 0.29 [95% CI −0.46; 1.03],
I2 = 74% (figure S9).
Four studies reporting on offspring LDL cholesterol, N = 78 ani-
mals between 28 days and 12 months of age, indicated that maternal
obesity increased offspring LDL cholesterol levels, SMD 0.53 [0.07;
0.98], I2 = 0% (figure S10).
3.6 | Glucose homeostasis
Sixty‐eight studies, including N = 1980 animals, reported on offspring's
glucose levels at birth until 12 months of age. One study was included
twice in the meta‐analysis since they reported on two different
cohorts.25 In five studies, we were unable to extract outcome
data.33,34,42-44 Glucose was higher in offspring of mothers with obe-
sity compared with offspring of control mothers, SMD 0.43 [95% CI
0.24; 0.63], I2 = 73% (figure S11).
Data from N = 70 studies, including N = 1975 animals from birth
to 12 months of age, showed higher insulin levels in offspring of
FIGURE 2 Effect estimates of maternal obesity before and during pregnancy on offspring outcomes [Colour figure can be viewed at
wileyonlinelibrary.com]
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mothers with obesity, SMD 0.81 [95% CI 0.61; 1.02], I2 = 75% (figure
S12). We could not extract offspring insulin levels from one study.42
Thirteen studies reported on HOMA‐IR, including N = 554 animals
between 20 days and 6 months of age. HOMA‐IR was higher in off-
spring of mothers with obesity compared with control mothers, SMD
0.54 [95% CI 0.14; 0.94], I2 = 74% (figure S13).
3.7 | Subgroup analyses
To account for the possible moderating effects of offspring sex
(male, female, overall; table S5 and figure S14‐S24), age (infancy,
juvenile, adult; table S6 and figure S25‐S29), and species (rodents,
non‐rodents; table S7 and figure S30‐S32), we performed subgroup
analyses for these determinants for all of the outcome variables (as
predefined in our protocol). Effect estimates were similar for
subgroups, indicating no differences based on offspring's sex, age,
or species (Figure 3A‐C).
3.8 | Study quality and publication bias
The results of the quality assessment of the included studies are
shown in table S3. Of the 71 (49%) studies reporting on randomiza-
tion, none reported the method of randomization. Five studies (3%)
reported on blinding, of which only one specified blinding of outcome
assessment,45 and one reported the investigators were not blinded.46
Four studies (3%) reported that a power calculation for one of the out-
comes used in our meta‐analyses had been performed.
Publication bias was analysed by inspection of the funnelplots and
trim and fill analyses. Only for birth weight publication bias was sug-
gested (figure S33). Inspection of the funnelplot of birthweight
showed significant asymmetry and trim and fill imputed 19 “missing”
studies (red dots). The adjusted overall effect size for birthweight is
−0.35 [95% CI −0.48; −0.22] (note: the SMD in the trim and fill analy-
sis is based on a different precision estimate, i.e., 1/√N instead of
SE).20
4 | DISCUSSION
In this meta‐analysis examining animal experiments of maternal obe-
sity before and during pregnancy, we found that maternal obesity
induced poorer cardiometabolic health in the offspring. More specifi-
cally, based on data of 145 included studies (N = 21 048 animals of
five species), we conclude that maternal obesity leads to higher adi-
posity and systolic blood pressure and negatively affects lipid, insulin,
and glucose homeostasis in the offspring. Maternal obesity does not
influence offspring birth weight. The effect of maternal obesity on off-
spring cardiometabolic health was independent of offspring sex, age,
or species.
Our findings are in line with a systematic review of animal
experiments showing that a maternal obesogenic diet during preg-
nancy negatively affects offspring's body weight, body composition,
and glucose homeostasis.15 Effect sizes from a meta‐regression of
maternal high‐fat diet during pregnancy on offspring adult body
weight, adiposity, total cholesterol, triglycerides, and insulin were in
the same direction and magnitude as our findings; however, in con-
trast to our findings, there was no statistically significant difference
for glucose in males.14 Similar to these animal systematic
reviews,14,15 but in contrast to human studies,47,48 no effect of
maternal obesity on birth weight was found. This could be due to
the fact that rodents are born relatively immature compared with
humans,49 and in humans fetal adiposity increased most rapidly in
the last weeks of gestation.50,51
This systematic review adds to the evidence that not only an
obesogenic diet during pregnancy but also obesity induced before
pregnancy has negative effects on offspring cardiometabolic health.
Also, since all offspring were fed a normal diet after weaning, we were
able to show that the diminished offspring health was independent of
offspring's own diet. Similar to our findings, observational data of
human cohort studies show that children from mothers with obesity
have higher risks of infant and childhood overweight/obesity,47,52
and cardiometabolic disease later in life.53,54 However, in human
observational studies, causality cannot be inferred because it is diffi-
cult to differentiate direct effects from residual confounding.55 Animal
experiments overcome this difficulty. The results of this systematic
review of animal experiments—maternal obesity is causal to offspring
adverse cardiometabolic health—do suggest that maternal obesity is
indeed likely causal to poorer offspring cardiometabolic health in
humans.53
4.1 | Potential mechanisms
The effect of maternal obesity on adverse cardiometabolic health in
the offspring may be explained by several mechanisms, including epi-
genetic changes, metabolic factors, inflammatory pathways and direct
structural effects, or a combination of these.4
Epigenetic mechanisms describe altered expression of genes with-
out altering the DNA sequence. Mostly animal experiments indicate
that fetal exposure to maternal obesity induces variance in
microRNAs, DNA methylation, and histone modification.56-58 These
processes, which influence gene expression, are largely established
during fetal development and affected by the intrauterine
enviroment.59 In turn, these epigenetic changes were associated with
increased hepatic triglycerides in primates and altered mouse brain
dopamine and opioid gene expression related to food behavior.60,61
Evidence from a limited number of human observation studies indicate
that similar mechanisms may be at work in the human situations; while
no global effect on methylation in obesity was seen, there were sev-
eral associations between specific methylation sites at birth and obe-
sity later in life.62
Second, accelerated fetal pancreatic maturation, induced by
maternal obesity‐related hyperglycemia, may lead to premature loss
of ß‐cells and consequently lead to permanently impaired glucose
and insulin homeostasis in offspring.63 Additionally, both high fetal
or neonatal insulin, leptin, or lipid levels may in part induce hypotha-
lamic programming,64,65 leading to hyperphagia and altered satiety
response.63,66,67 Also, maternal obesity during pregnancy may induce
fetal adipocyte hypertrophy and by upregulating lipoprotein lipase
and peroxisome proliferator‐activated receptor gamma (PPARy)
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activity in the adipocyte modify their fatty acid composition.10,68,69
This could lead to obesity and metabolic disturbances in the off-
spring later in life.
Third, the low‐grade inflammation seen in obesity could also con-
tribute to offspring's risks of cardiometabolic disease, since upregula-
tion of inflammatory markers is seen in children of mothers with
obesity, independent of offspring's BMI.70,71
Lastly, direct structural effects of maternal obesity include fetal
cardiac hypertrophy72,73 and aortic stiffness,74 each of which predis-
pose to hypertension. This risk of hypertension is further augmented
by selective leptin resistance and increased sympathetic nervous sys-
tem activity in the offspring.75
4.2 | Clinical relevance
No animal model perfectly represents the human situation, and this
limits the generalizability of our results to the human situation. For
example, there is no animal model that fully resembles human
placentation.76 Additionally, in the vast majority of the included
animal experiments, maternal obesity was induced by high‐fat diets.
While these diets do induce obesity and metabolic disorders that
resemble human obesity, there is heterogeneity in their composition
and lack of standardization.77 Moreover, human obesity may be
more strongly related to high carbohydrate intake than fat intake,
and the role of (low) physical activity is often not accounted for in
animal studies.78,79 Nevertheless, for most outcomes, there was a
large evidence base containing multiple species with comparable
direction of effects increasing our confidence that maternal obesity
before and during pregnancy causes obesity and hypertension and
negatively affects lipid and glucose homeostasis also in human
offspring.
Animal experiments have suggested a transgenerational effect of
obesity: maternal obesity may not only affect the offspring, but
the negative effects may be carried over to subsequent genera-
tions.80-82 For example, the second generation of obese
overnourished ewes showed increased adiposity and higher blood
glucose and insulin levels compared with controls, independent of
their mother's weight.81 Thus, our findings have a profound public
health implication. Our results could be useful in developing strate-
gies to prevent adverse health outcomes among children of mothers
with obesity.53 Whether interventions aimed at reducing obesity in
women of childbearing age could improve maternal and child's health
needs to be investigated further. Some animal experiments provide
evidence that exercise or dietary interventions during pregnancy
could reverse the detrimental effects of maternal obesity on the
offspring,83-87 with potential sex differences.85,87 In humans how-
ever, only a limited amount of studies examined the consequences
of reducing maternal obesity on offspring health. In observational
studies, maternal weight loss through bariatric surgery was
associated with lower adiposity and improved lipids in offspring.88,89
However, only two lifestyle intervention showed a favorable effect
on infants,90,91 while others found no effect on childhood anthro-
pometry and cardiometabolic health.92
4.3 | Strengths and limitations
Strengths of this research are that we performed a broad and inclusive
search of the available literature. Second, we only included studies
where maternal obesity was present before and during pregnancy,
which more closely resembles human conditions. Third, we were able
to exclude possible confounding postnatal effects; i.e., we included
only the offspring fed a normal diet after weaning.
However, there are several methodological limitations that may
impact the generalizability and validity of our findings. First, the vast
majority of the studies used rodent models. Larger animal models
could be of closer parallel to human development.93 Subgroup analysis
of rodents versus other species was only possible for selected out-
comes (birth weight, body weight, insulin), due to limited numbers of
non‐rodent models. While these subgroup analyses showed a similar
direction of effect, future studies including non‐rodent models are
needed to establish whether non‐human primates for example do in
fact display the same responses to maternal obesity as rodents.94
Second, studies reported poorly on important methodological
details (randomization, blinding, and power calculation). This ham-
pered reliable risk of bias assessment and may reduce the reliability
of our conclusions. Therefore, consistent reporting of essential details
regarding experimental design, as described for example in the
ARRIVE guidelines,95 is needed in future animal studies.
Third, although we accounted for heterogeneity by using a ran-
dom rather than a fixed effect model for meta‐analysis, variation
between the studies was high. A recent study has suggested evidence
of sex‐dependent differences in pathways related to CVD develop-
ment.96 Our subgroup analyses based on offspring sex showed no dif-
ferences in effects; however, not all studies could be included because
of missing data on males and females separately. Further, we per-
formed pre‐specified subgroup analyses for age and species of the off-
spring, but these factors also did not explain the heterogeneity. Other
factors, such as the maternal diet during lactation and timing of expo-
sure, may explain the variation observed.14 Standardizing dietary com-
position and duration and intensity of maternal obesity induction
might reduce this form of heterogeneity and may help unravel modify-
ing factors of the effect of maternal obesity on the offspring.77
Fourth, we only observed potential publication bias for the out-
come birth weight by trim and fill analysis. When we adjusted for pub-
lication bias, we observed a significant lower birth weight in offspring
of mothers with obesity. Since the trim and fill method may inappro-
priately adjust for publication bias when there is substantial
between‐study heterogeneity,97,98 the true effect of maternal obesity
on offspring's birth weight remains uncertain.
5 | CONCLUSION
In conclusion, this systematic review of animal experiments provides
strong evidence that maternal obesity before and during pregnancy
causes obesity and hypertension and negatively affects lipid and glu-
cose homeostasis in the offspring in animals. These findings are impor-
tant since the incidence of obesity among women of child bearing age
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is increasing. Targeting obesity in women in the pre‐pregnancy period
could play a pivotal role to improve health in future generations and
warrants intervention studies. Yet, issues need to be addressed,
including the translation of the results to human populations.
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